| 93349-9 |
Treatment to which interaction between genetic variants confers resistance |
Prid |
Bld/Tiss |
Pt |
Nom |
|
|
ACTIVE |
Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93349-9 |
|
|
|
|
Observation |
|
|
|
0 |
Variant interaction assoc therapy resist |
|
|
|
|
|
Blood; Genetics; Genomic; Identity or presence; Interaction assoc tx resist; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Tissue; Tissue, unspecified; Tx; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9335-1 |
Observation |
Aper |
Body fld |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Body fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
9335-1 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance Fld |
|
|
|
|
|
Appearance; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC |
2.79 |
1.0i |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
| 93350-7 |
Monocytes.HLA-DR/Monocytes |
NFr |
Bld |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Monocytes.HLA-DR/Monocytes in Blood by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
93350-7 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Mono.HLA-DR/Monocytes NFr Bld FC |
|
|
|
|
|
Blood; CELL MARKERS; Dynamic; FC; Human Leukocyte Antigen; I3; Mono; Mono.HLA-DR; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.79 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 93351-5 |
HLA-DR Ag |
EntNum |
Monocyte |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
#/cell |
|
|
|
|
|
|
CELLMARK |
|
93351-5 |
|
Flow cytometry |
|
|
Both |
|
|
|
0 |
HLA-DR Ag EntNum Mono FC |
|
|
|
|
|
Antigen; Antigens; CELL MARKERS; Dynamic; Entitic; Entitic number; FC; Human Leukocyte Antigen; I3; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
{#}/{cell} |
|
|
|
0 |
| 93352-3 |
Neutrophils.CD64/Neutrophils |
NFr |
Bld |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Neutrophils.CD64/Neutrophils in Blood by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
93352-3 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Neut.CD64/Neutrophils NFr Bld FC |
|
|
|
|
|
Blood; CELL MARKERS; Dynamic; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Neut; Neut.CD64; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.79 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 93353-1 |
CD64 Ag |
EntNum |
Neutrophil |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
#/cell |
|
|
|
|
|
|
CELLMARK |
|
93353-1 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
CD64 Ag EntNum Neut FC |
|
|
|
|
|
Antigen; Antigens; CELL MARKERS; Dynamic; Entitic; Entitic number; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
{#}/{cell} |
|
|
|
0 |
| 93354-9 |
Neutrophil CD64 & Monocyte HLA DR panel |
- |
Bld |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
93354-9 |
|
Flow cytometry |
|
|
Order |
|
|
|
0 |
Neut CD64 + Mono HLA DR Pnl Bld FC |
|
|
|
|
|
Blood; CELL MARKERS; Dynamic; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; HLA-DR; Human Leukocyte Antigen; I3; Neut; Neut CD64 + Mono HLA DR Pnl; Neutr; Neutrophils; Pan; PANEL.CELLMARK; Panl; PMN; Pnl; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 93356-4 |
Cells.cytogenetic abnormality |
Num |
Bld/Tiss |
Pt |
Qn |
Molgen |
|
ACTIVE |
Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
MOLPATH |
|
93356-4 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Cells w cytogenetic abnl Bld/T |
|
|
|
|
|
Blood; Cell; Cells w cytogenetic abnl; Cellularity; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
| 93357-2 |
Monotypic plasma cell identification & risk stratification panel |
- |
Bone mar |
Pt |
- |
Molgen |
|
ACTIVE |
Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MOLPATH |
|
93357-2 |
|
Molgen |
|
|
Order |
|
|
|
0 |
Mono PC ID + risk Pnl Mar |
|
|
|
|
|
BM; BON; Bone marrow; Leukemia; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; Mono PC ID + risk Pnl; Monoclonal; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloproliferative Disorder; Pan; Panel.molpath; Panl; PCR; Plasma cell myeloma; Pnl; Point in time; Random |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 93358-0 |
Plasma cells.polyclonal/Cells counted |
NFr |
Bone mar |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
93358-0 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Polyclonal PCs/Cells NFr Mar FC |
|
|
|
|
|
BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; Polyclonal PCs; QNT; Quan; Quant; Quantitative; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 93359-8 |
Monotypic plasma cell DNA ploidy |
Type |
Bone mar |
Pt |
Nom |
Flow cytometry |
|
ACTIVE |
Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93359-8 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Monotypic PC DNA ploidy Mar FC |
|
|
|
|
|
BM; BON; Bone marrow; Deoxyribonucleic acid; DNA content; Dynamic; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Monotypic PC DNA ploidy; Nominal; Point in time; Random; Typ |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9336-9 |
IgA subclass 1/IgA.total |
MFr |
Ser |
Pt |
Qn |
|
|
ACTIVE |
IgA subclass 1/IgA.total in Serum |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
9336-9 |
|
|
|
|
Observation |
|
|
|
0 |
IgA1 MFr Ser |
|
|
|
Y |
|
Chemistry; i; IgA1; Immune globulin A; Immunoglobulin A; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses; Tot; Totl |
2.73 |
1.0i |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 93360-6 |
Monotypic plasma cell DNA index |
Ratio |
Bone mar |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
MOLPATH |
|
93360-6 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Monotypic PC DNA index Mar FC-Rto |
|
|
|
|
|
BM; BON; Bone marrow; Deoxyribonucleic acid; DI; DNA score; Dynamic; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Monotypic PC DNA index; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto |
2.67 |
2.67 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 93361-4 |
Plasma cells.monotypic.S phase/Cells |
NFr |
Bone mar |
Pt |
Qn |
Flow cytometry |
|
ACTIVE |
Monotypic plasma cells in S phase/cells in Bone marrow by Flow cytometry (FC) |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
MOLPATH |
|
93361-4 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Mono PC in S Phs NFr Mar FC |
|
|
|
|
|
BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Mono PC in S Phs; Monoclonal; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloma cells; Number fraction; Percent; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime |
2.79 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 93362-2 |
Plasma cells.monotypic population |
Prid |
Bone mar |
Pt |
Nom |
Flow cytometry |
|
ACTIVE |
Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
93362-2 |
|
Flow cytometry |
|
|
Observation |
|
|
|
0 |
Monotypic plasma cells Mar FC |
|
|
|
|
|
BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Identity or presence; Leukemia; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Monoclonal; Monotypic plasma cells; Multiple myeloma; Myeloma cells; Nominal; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93363-0 |
Plasma cell DNA content & proliferation panel |
- |
Bone mar |
Pt |
- |
Flow cytometry |
|
ACTIVE |
Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
93363-0 |
|
Flow cytometry |
|
|
Order |
|
|
|
0 |
PC DNA content + prolif Pnl Mar FC |
|
|
|
|
|
BM; BON; Bone marrow; Cell cycle analysis; Deoxyribonucleic acid; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloproliferative Disorder; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PC DNA content + prolif Pnl; Ploidy; Pnl; Point in time; Random |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 93364-8 |
Genetic variant diagnostic significance |
Imp |
Bld/Tiss |
Pt |
Nar |
|
|
ACTIVE |
Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93364-8 |
|
|
|
|
Observation |
|
|
|
0 |
Genetic variant diag sig Bld/T-Imp |
|
|
|
|
|
Blood; Genetic variant diag sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93365-5 |
Genetic variant prognostic significance |
Imp |
Bld/Tiss |
Pt |
Nar |
|
|
ACTIVE |
Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93365-5 |
|
|
|
|
Observation |
|
|
|
0 |
Genetic variant prog sig Bld/T-Imp |
|
|
|
|
|
Blood; Genetic variant prog sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93366-3 |
Gene studied with no variant found |
Prid |
Bld/Tiss |
Pt |
Nom |
|
|
ACTIVE |
Gene studied with no variant found [Identifier] in Blood or Tissue Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93366-3 |
|
|
|
|
Observation |
|
|
|
0 |
Gene studied w no variant found Bld/T |
|
|
|
|
|
Blood; Gene studied w no variant found; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93367-1 |
Variant of unknown significance |
Prid |
Bld/Tiss |
Pt |
Nom |
|
|
ACTIVE |
Variant of unknown significance [Identifier] in Blood or Tissue Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93367-1 |
|
|
|
|
Observation |
|
|
|
0 |
Variant unknown sig Bld/T |
|
|
|
|
|
Blood; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; Variant unknown sig; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93368-9 |
Summary of interaction between genetic variants |
Imp |
Bld/Tiss |
Pt |
Nar |
|
|
ACTIVE |
Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93368-9 |
|
|
|
|
Observation |
|
|
|
0 |
Variant interaction summary Bld/T-Imp |
|
|
|
|
|
Blood; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; Variant interaction summary; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93369-7 |
Krebs von den Lungen-6 |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
CHEM |
|
93369-7 |
|
IA |
|
|
Both |
|
|
|
0 |
KL-6 SerPl IA-aCnc |
|
|
|
|
|
Arbitrary concentration; Chemistry; Disease, Interstitial Lung; Diseases, Interstitial Lung; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ILD; Interstitial Lung Disease; KL-6; MEIA; MUC1; Mucin, Muc1; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.67 |
2.67 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
| 9337-7 |
IgA subclass 1/IgA.total |
MFr |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated IgA subclass 1/IgA.total in Serum |
|
DEL |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
9337-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated IgA1 Fr Ser |
|
|
|
|
|
Chemistry; i; IgA1; Immune globulin A; Immunoglobulin A; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses; Tot; Totl |
2.46 |
1.0i |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 93370-5 |
Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
93370-5 |
|
|
|
|
Order |
|
|
|
0 |
A phagocyt + E chaff IgG + IgM Pnl Ser |
|
|
|
|
|
A phagocyt + E chaff IgG + IgM Pnl; E chaff IgG+IgM Pnl; E chaffeensis; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; HME; Human granulocytic ehrlichiosis; Human monocytic ehrlichiosis; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 93371-3 |
von Willebrand factor cleaving protease activity |
CCnc |
PPP |
Pt |
Qn |
Chromo |
|
ACTIVE |
von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
COAG |
|
93371-3 |
|
Chromo |
|
|
Both |
|
|
|
0 |
vWF Cp Act PPP Chro-cCnc |
|
|
|
|
|
Activ; Actvty; ADAMTS13; ADAMTS-13; Catalytic Concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Fac; Fact; FRET; Movements; Plas; Platelet poor plasma; Point in time; PR; QNT; Quan; Quant; Quantitative; Random; TTP; Von will; Vonwillebrand; vWCP; vWf; vWF Cp; vWF Cp Act; VWFCP; VWF-cp |
2.68 |
2.67 |
|
|
|
|
|
|
|
U/mL |
|
|
|
0 |
